Rocket Lab, the California-based aerospace and defense innovator, has found itself at the epicenter of investor excitement and scrutiny after a week marked by major contract wins, technical milestones, and some lingering questions about its ambitious Neutron rocket program. On March 18, 2026, shares of Rocket Lab (NASDAQ: RKLB) surged 10.2% to close at $78.45, riding a wave of positive news that drew both Wall Street’s optimism and its caution.
The immediate catalyst for Rocket Lab’s rally was the company’s announcement of critical progress on its Neutron rocket, a medium-lift launch vehicle that could redefine the company’s role in the commercial and defense space sectors. According to multiple sources, including Meyka and industry analysts, Rocket Lab confirmed that key components—specifically the so-called 'Hungry Hippo' fairing and the thrust structure—had been successfully qualified for final integration. These milestones are far from trivial; they reduce major design risks and keep the company on track for Neutron’s first launch, now targeted for the fourth quarter of 2026.
"Each qualified milestone narrows uncertainty around cost, schedule, and payload performance," noted Meyka, underscoring why tangible hardware advances matter more to investors than mere presentations or theoretical plans. The technical achievements support the rocket’s structural integrity, separation systems, and engine mounts, all essential for a successful debut.
The Neutron rocket, once anticipated for a 2025 launch, has faced a series of delays. Most recently, on February 26, 2026, Rocket Lab disclosed that a ruptured main stage tank—caused by a contractor’s manufacturing defect—would push the first flight back to at least Q4 2026. The company said it was prioritizing caution and quality, but the repeated postponements have raised eyebrows among analysts. As one industry observer put it, "the extent of the delay leads me to believe that the problem could be difficult to fix." Still, each step forward on Neutron, like the latest hardware qualifications, has offered reassurance that the project remains viable.
While Neutron’s timeline remains a swing factor for the stock, Rocket Lab’s broader business has rarely looked stronger. In December, the company landed its largest-ever contract: an $816 million deal with the U.S. Space Development Agency (SDA) to design and build 18 advanced missile-warning and defense satellites for the Tracking Layer Tranche 3 (TRKT3) program under the Proliferated Warfighter Space Architecture. As reported by The Street and other outlets, this contract not only signals deep trust from the U.S. government but also cements Rocket Lab’s growing importance in national security space initiatives.
The company’s financials reflect this momentum. Rocket Lab reported record 2025 revenue of $179.65 million in the fourth quarter, up from $132.39 million in the same period a year earlier. The company’s backlog—a key measure of future business—soared 73% to a record $1.85 billion by the end of 2025, supported by more than 30 new launch contracts signed during the year. Rocket Lab’s gross margin now sits near 34.4%, with a healthy liquidity position (current ratio of 4.08 and $1.78 cash per share) and an R&D intensity of about 45% of revenue, reflecting heavy investment ahead of Neutron’s long-awaited debut.
Beyond launch vehicles, Rocket Lab has expanded its portfolio into hypersonic flight and space-based infrastructure. On February 27, 2026, the company’s rocket platform successfully powered a hypersonic flight, enabling an aircraft to travel at speeds several times faster than sound—a milestone that has already generated multiple deals and "several billion dollars" in revenue, according to sector reporting. The company also recently introduced advanced silicon solar arrays designed to power gigawatt-scale space-based data centers, a potentially lucrative business as tech giants like Elon Musk and Jeff Bezos tout the future of orbital computing.
Despite these achievements, not everyone is convinced that Rocket Lab is a risk-free bet. The company’s shares are notoriously volatile, with 76 moves greater than 5% over the past year. The stock is currently trading about 20.7% below its 52-week high of $96.30 set in January 2026, and its valuation remains steep—about 72.7 times sales and 25.6 times book value, with negative earnings and only recently improving free cash flow. As one analyst put it, "By traditional metrics it is expensive. Bulls argue growth, backlog, and Neutron can justify premiums. Bears focus on execution risk and cash burn."
Insider activity has also drawn attention. On March 2, 2026, Rocket Lab CFO Adam Spice sold 59,714 shares worth approximately $4.3 million, following a much larger sale of 1.387 million shares in January. Some market watchers interpret these moves as a sign of uncertainty about the company’s medium-term outlook, though others note that executives routinely sell shares for a variety of reasons.
Trading activity in RKLB stock has been brisk, with March 18 seeing volume spike to 28.5 million shares—well above the 22.6 million average. Technical indicators are mixed: the RSI sits near 49.1 (not signaling overbought or oversold), ADX is 12.3 (suggesting no strong trend), and the MACD histogram has turned slightly positive. The stock pressed above its Bollinger mid-band, a constructive sign for near-term momentum, but with an average true range (ATR) of 5.37, daily swings of 6% to 8% are common. In short, volatility is part of the Rocket Lab experience.
Looking ahead, the company’s next earnings report on May 7, 2026, will be closely watched for updates on backlog, margins, and Neutron’s progress. Key technical milestones for Neutron in 2026 include stage integration, engine and structural qualification, avionics testing, and fairing separation verification, as well as launch site readiness and regulatory approvals. Each successful checkpoint will likely move the stock, given how much of Rocket Lab’s valuation is tied to Neutron’s future.
Sector sentiment has also been lifted by speculation about a potential SpaceX IPO, which has led investors to revalue pure-play launch companies like Rocket Lab. The hope is that a SpaceX listing would provide a richer set of comparables and boost the entire sector’s profile among institutional investors.
For now, Rocket Lab stands at a crossroads. Its operational momentum, record backlog, and expanding presence in hypersonics and space infrastructure are undeniable strengths. But delays to Neutron, high valuation multiples, and insider sales temper the bullish narrative. As one analyst summarized, "While Rocket Lab appears well positioned for long-term growth in the space and defense sectors, the current risk profile suggests investors may want to remain cautious for now."
With its next chapter hinging on flawless execution and timely delivery, Rocket Lab’s journey is far from over—and investors will be watching every milestone, launch, and contract win with bated breath.